New Clinical Trial in MDR-TB Care to Support Hardest to Treat Patients Globally
Q&A with Dr. Carole Mitnick, PIH’s co-principal investigator of endTB project Posted on Dec 22, 2020 An extensively drug-resistant tuberculosis patient is examined as part of the endTB project at Sergio E. Bernales Hospital in Carabayllo, a northern district of Lima, Peru. Photo by William Castro Rodriguez for Partners In Health Tuberculosis is the most deadly infectious disease, killing more than 1.4 million people globally, most of them in resource-poor countries. Some forms of the disease are resistant to treatment and therefore can’t be cured using standard drugs. These multi...